The MONET is a U.S. Food and Drug Administration-approved, integrated anterior cervical fusion system, designed with patients in mind. It features streamlined instrumentation, cage material offerings in both titanium and PEEK, and anterior plating in low-profile, four-screw and zero-profile, two-screw configurations. This provides surgeons with a variety of construct options and allows true intra-operative flexibility.
“The MONET enables greater flexibility during anterior cervical spine surgery, which can help surgeons to better serve their patients’ individual needs,” says Daniel Chon, CTL Amedica president and CEO. “We’ve been working on the product for quite some time and received FDA approval to market it several months ago. We’re excited to officially unveil it to the spine community at NASS.”
NASS is the largest spine meeting and exhibition worldwide. The North American Spine Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CTL Amedica Corporation is a medical device company headquartered in Dallas that designs, develops and manufactures spinal implants and instruments that are tailored to fit the unique needs of both surgeons and patients. It maintains an in-house manufacturing facility and an R&D Center of Excellence, and it provides a full line of cervical, thoracic and lumbar products. It also is the world’s exclusive provider of silicon nitride spine products. Silicon nitride demonstrates unique bacteriostatic properties, provides superior imaging across all modalities and fosters an enhanced osteogenic response.